Inflammatory cytokines in the pathogenesis of periventricular leukomalacia

Neurology

Volumn 56, Issue 10, 2001, Pages 1278-1284

  Kadhim, Hazim ^a,b   Tabarki, B ^a   Verellen, G ^b   De Prez, C ^a   Rona, A M ^a   Sebire G ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD68 ANTIGEN; CELL ADHESION MOLECULE; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CEREBRAL PALSY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOREACTIVITY; INFLAMMATION; LEUKOMALACIA; MALE; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0035933039     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.10.1278     Document Type: Article

References (39)

1. Volpe JJ. Neurology of the newborn. Philadelphia, PA: WB Saunders, 1995.
2. Kuban KCK, Leviton A. Cerebral palsy. N Engl J Med 1994; 330:188-195.
3. Banker BQ, Larroche JC. Periventricular leukomalacia of infancy. Arch Neurol 1962;7:386-410.
4. Friede RL. Developmental neuropathology. New York, NY: Springer-Verlag, 1989.
5. Hagberg B, Hagberg G, Olow I, Wendt L. The changing panorama of cerebral palsy in Sweden: VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr 1996;85:954-960.
6. Topp M, Uldall P, Langhoff-Ross J. Trend in cerebral palsy birth prevalence in eastern Denmark: birth-year period 1979-86. Paediatr Perinat Epidemiol 1997;11:451-460.
7. Volpe JJ. Brain injury in the premature infant: from pathogenesis to prevention. Brain Dev 1997;19:519-534.
8. Graham DI, Lantos PL. Greenfield's neuropathology. London, UK: Arnold, 1997.
9. Fanaroff AA, Hack M. Periventricular leukomalacia: prospects for prevention. N Engl J Med 1999;341:1229-1230.
10. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-675.
11. Zupan V, Gonzalez P, Lacaze-Masmonteil T, et al. Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol 1996;38:1961-1967.
12. Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-1196.
13. Leviton A, Paneth N. White matter damage in preterm newborns - an epidemiologic perspective. Early Hum Dev 1990;24: 1-22.
14. Yoon BH, Romero R, Yang SH, et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433-1440.
15. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukine-6, interleukine-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
16. Baud O, Emilie D, Pelletier E, et al. Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol 1999; 106:72-77.
17. Aloisi F, Ria F, Adorini L. Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today 2000;21:141-147.
18. Kadhim H, Guzman Proano P, Saint Martin C, et al. Spinal neurenteric cyst presenting in infancy with chronic fever and acute myelopathy. Neurology 2000;54:2011-2015.
19. Cai Z, Pan Z-L, Pang Y, Evans OB, Rhodes PG. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000;47:64-72.
20. Yoon BH, Romero R, Kim CJ, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997;177:797-802.
21. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23: 339-346.
22. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF. Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by lymphotoxin. J Immunol 1991;147:1522-1529.
23. Louis JC, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993;259:689-692.
24. Cammer W, Zhang H. Maturation of oligodendrocytes is more sensitive to TNF-α than is survival of precursors and immature oligodendrocytes. J Immunol 1999;97:37-42.
25. Cammer W. Effects of TNF alpha on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 2000;864:213-219.
26. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci USA 1995;92:11294-11298.
27. Taupin V, Renno T, Bourbonnière L, Peterson AC, Rodriguez M, Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system. Eur J Immunol 1997;27:905-913.
28. Körner H, Riminton DS, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med 1997;186:1585-1590.
29. Eugster HP, Frei K, Bachmann R, Bluethmann H, Lassman H, Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur J Immunol 1999; 29:626-632.
30. Juedes AE, Hjelmström P, Bergman CM, Neil AL, Ruddle NH. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 2000;164:419-426.
31. Dommergues M-A, Patkai J, Renauld J-C, Evrard P, Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000;47:54-63.
32. Sharief MK, Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-472.
33. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170:607-612.
34. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-582.
35. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes: differential induction by lipopolysaccharide and IL-1β. J Immunol 1993;150:2659-2667.
36. Sébire G, Emilie D, Wallon C, et al. In vitro production of IL-6 IL-1β, and tumor necrosis factor-α by human embryonic microglial and neural cells. J Immunol 1993;150:1517-1523.
37. Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991;147:4307-4312.
38. Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor-α and interleukine-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-411.
39. Deguchi K, Mizuguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia. Pediatr Neurol 1996;14:13-16.